Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-08-19
    E.g., 2018-08-19

Archive Search

1 results
12:00 AM, Mar 16, 2015  |  BC Week In Review | Clinical News  |  Regulatory

Beteflam Patch regulatory update

Health Canada accepted for review an NDS for Beteflam Patch from Cipher Pharmaceuticals Inc. (TSX:CPH; NASDAQ:CPHR, Mississauga …
deal granting Cipher marketing rights to the product in Canada (see BioCentury, Aug. 13, 2012). Beteflam Patch
self-adhesive medicated plaster containing 0.1% betamethasone valerate. Institut Biochimique S.A. , Lugano, Switzerland   Product: Beteflam Patch